For Medical Use OnlyThe New York State Department of Health recently proposed a new set of regulations that would loosen marketing and advertising laws affecting New York’s medical cannabis program. The proposed regulations were published in the New York Register on August 23, 2017, and are open for a 30-day public comment period before the new regulations are to take effect.

The proposed regulations ease restrictions for registered organizations and dispensing facilities’ exterior signage by eliminating the previous requirement that all registered cannabis dispensaries display no more than one exterior black-and-white sign. The new regulations also removes the previous restriction that banned dispensaries from illuminating, “at any time, a sign advertising a marihuana product located on any physical structure.”

Continue Reading Proposed Regulations Update Advertising for Cannabis Organizations

Picture by slgckgc  (CC BY 2.0)
Picture by slgckgc (CC BY 2.0)

The reasonable consumer couldn’t possibly believe that every Danish cookie, must, as a matter of law, be made in Denmark.  Yet, a recent NAD decision may suggest that this reasonable consumer is not as cookie-cutter as one might expect.

In today’s global economy, it is common for U.S. distributors to sell products manufactured and packaged overseas.  A downside of this system, is that neither the distributors nor the sellers can necessarily oversee each advertising claim placed on the product’s packaging.  This practice contradicts a recent NAD decision, which warns that before a seller can distribute an international product throughout the United States, it should be cognizant of any and all claims found on the product’s packaging. 
Continue Reading Distributors Beware: Don’t Get Caught with Your Hand in the Cookie Jar